Pharmacogenomics & Pharmacoproteomics

Pharmacogenomics & Pharmacoproteomics is the study of the use of genetics in drug response and provided DNA for genomes. It deals with the influence of acquired and inherited genetic variation on drug response in patients by Protein aggregation & stability in biopharmaceuticals, New discoveries in genomic targets, Various drug responses due to genetic polymorphisms, Drug dosage formulations, Drug safety and its efficiency and Membrane transport proteins.

  • Protein aggregation and stability in biopharmaceuticals
  • New discoveries in genomic targets
  • Various drug responses due to genetic polymorphisms
  • Drug dosage formulations
  • Drug safety and its efficacy
  • Membrane transport proteins

Related Conference of Pharmacogenomics & Pharmacoproteomics

August 15-16, 2018

16th Asia Pacific Biotechnology Congress

Singapore
August 27-28, 2018

5th International Conference on Glycobiology & Glycoproteomics

Toronto, Ontario, Canada
August 27-28, 2018

3rd International Conference on Molecular Biology & Nucleic Acids

Toronto, Ontario, Canada
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany
October 03-04, 2018 |

4th International Conference on Biochemistry & Metabolomics

Los Angeles, California, USA
October 18-19, 2018

10th International Congress on Structural Biology

Helsinki, Finland
November 19-20, 2018

15th World Congress on

Structural Biology

Paris, France
February 28-March 01, 2019

5th International Conference on Enzymology and Protein Chemistry

Berlin, Germany

22nd Global Congress on Biotechnology

February 28-March 02, 2019 Berlin, Germany

Pharmacogenomics & Pharmacoproteomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in